Fennec Pharmaceuticals FENC
NASDAQ FENC
$12.39 -0.16 (-1.28%)
As of: Sep 4, 2026 · 3:59 PM EDT

Fennec Pharmaceuticals (FENC) FCF Margin Growth (1y) (2024 - 2025)

Analysis

Fennec Pharmaceuticals (FENC) FCF Margin Growth (1y) (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -89.00
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -1,183.00
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 26,102.00
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 869.00
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 769.00
8 Royalty Pharma 28.45 Bn 27.61 Bn - 811.00
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 19,111.00
10 Fennec Pharmaceuticals 432.85 Mn 391.60 Mn 17.15 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -2,468.00
Sep 30, 2025 4,361.00
Jun 30, 2025 7,730.00
Mar 31, 2025 -19,635.00
Dec 31, 2024 3,132.00
Sep 30, 2024 1,073.00
Jun 30, 2024 319.00
Mar 31, 2024 47,957.00